PortViewPortView
Perrigo logo

Perrigo (PRGO) Stock Analysis

NYSEHealthcareDrug Manufacturers - Specialty & Generic

$14.79+2.49%
1-year price historyRange $9.25 – $23.33
52-week range$14.79
$9.23$23.68

What Perrigo does

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Key metrics

Market cap
$2.05B
P/E (TTM)
5.92
EPS (TTM)
$2.50
Beta
0.54
Dividend yield
7.84%
Revenue / share
$29.80
50-day avg
$11.65
200-day avg
$12.19
52-week high
$23.68
52-week low
$9.23
CEO
Albert A. Manzone

ETFs linked to PRGO

Broad-market and Healthcare sector ETFs an investor holding Perrigo is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PRGO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PRGO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Perrigo?
Perrigo trades under the ticker PRGO on NYSE.
Which exchange is PRGO listed on?
PRGO is listed on NYSE.
What sector does Perrigo operate in?
Perrigo is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze PRGO in a portfolio?
PortView shows PRGO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.